newsfilter
← Latest News
Business Wire·

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference

  • Verastem Oncology (NASDAQ: VSTM) announced its management team will attend a fireside chat at the 8th Annual Evercore Healthcare Conference.
  • The event is scheduled for Tuesday, December 2, 2025, at 10:25 am ET in Miami, Florida.
  • A live webcast will be available under "Events & Presentations" on the company website at www.verastem.com.
  • A replay of the webcast will be archived on the website for approximately 90 days following the presentation.
  • Verastem Oncology develops & commercializes medicines for RAS/MAPK pathway-driven cancers.
  • The company markets AVMAPKI™ FAKZYNJA™ CO-PACK in the U.S.
  • The company's pipeline includes novel small molecule drugs targeting RAF/MEK inhibition, FAK inhibition, & KRAS G12D inhibition.